Flu

The Pharmacy Times® Flu resource center provides information about early symptoms of the flu and the array of therapies in development intended to treat it as it progresses. Additionally, learn more about the data coming directly from the most widely attended pharmacy conferences and meetings, updated clinical trial listings, and other resources.

Beyond the Bench: Advancing Vaccine Education
What can we help you find?
[[thumbnail_alt_text]]
According to findings from a December 2020 national survey, more US adults reported receiving or planning to receive an influenza vaccination during the 2020-2021 flu season than ever before.
[[thumbnail_alt_text]]
The estimate is based on a new analysis of out-of-pocket costs for influenza-related hospitalizations in 2018 that were paid by people with Medicare Advantage plans, which are Medicare plans run by private insurance companies.
[[thumbnail_alt_text]]
Pharmacists can learn from previous mistakes to prepare for COVID-19 vaccination campaigns.
[[thumbnail_alt_text]]
Influenza treatment with antivirals was presented during a virtual symposium held in conjunction with the first virtual ASHP Midyear Clinical Meeting and Exhibition.
[[thumbnail_alt_text]]
Three international cardiovascular outcomes trials are currently examining the cardioprotective effects of different influenza vaccine formulations.
 
[[thumbnail_alt_text]]
Four patient cases involving OTC treatments are presented.
[[thumbnail_alt_text]]
All the states that passed laws require flu vaccines to be offered to hospital employees.
[[thumbnail_alt_text]]
Macrophages could be critical treatment targets because they could be infected by SARS-CoV-2 and can contribute to spreading the infection through the lung.
 
[[thumbnail_alt_text]]
B.1.1.7, or otherwise known as VOC 202012/01, may lead to a large increase in the number of COVID-19 cases in the United States and may become the dominant strain of the virus in the coming months.
[[thumbnail_alt_text]]
For patients with COVID-19, mitochondria are one of the first lines of defense in fighting the virus.
[[thumbnail_alt_text]]
Approximately one-third of children with COVID-19 are asymptomatic, according to a study conducted by researchers at the University of Alberta.
[[thumbnail_alt_text]]
Moderna, Inc has also announced temporary authorization of its COVID-19 vaccine in Switzerland.